PHGE - BiomX

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• BiomX GAAP EPS of -$0.20
• BiomX nets ~$7.2M after closing private placement of shares
• BiomX GAAP EPS of -$0.95 beats by $0.02
• BiomX to raise $7.5M in stock offering to institutional and individual investors
• BiomX GAAP EPS of -$0.23 in-line
• BiomX GAAP EPS of -$0.25 beats by $0.02
• BiomX to delist from Israeli stock exchange
• BiomX stock rises on team up with Boehringer inflammatory bowel disease biomarkers
• BiomX begins dosing of BX004 in trial to treat respiratory infections in cystic fibrosis patients
• BiomX GAAP EPS of $0.27 beats by $0.57
• BiomX GAAP EPS of -$1.39 misses by $1.11
• BiomX secures $5M award to advance BX004 in Cystic Fibrosis
• BiomX EPS misses by $0.07
• BiomX shares fall after mid-stage results from BX001 skin acne study
• BiomX pops 8% after atopic dermatitis candidate, BX005 deal with Maruho
• BiomX EPS beats by $0.07
• BiomX under pressure on launch of $15M direct offering
• BiomX expects BX001 Phase 2 data in Q3 after completing enrollment in trial for acne-prone skin
• BiomX EPS beats by $0.72
• BiomX reports Q4 results